Arsenijevic, T.; Coulonval, K.; Raspé, E.; Demols, A.; Roger, P.P.; Van Laethem, J.-L.
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges. Cancers 2023, 15, 968.
https://doi.org/10.3390/cancers15030968
AMA Style
Arsenijevic T, Coulonval K, Raspé E, Demols A, Roger PP, Van Laethem J-L.
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges. Cancers. 2023; 15(3):968.
https://doi.org/10.3390/cancers15030968
Chicago/Turabian Style
Arsenijevic, Tatjana, Katia Coulonval, Eric Raspé, Anne Demols, Pierre P. Roger, and Jean-Luc Van Laethem.
2023. "CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges" Cancers 15, no. 3: 968.
https://doi.org/10.3390/cancers15030968
APA Style
Arsenijevic, T., Coulonval, K., Raspé, E., Demols, A., Roger, P. P., & Van Laethem, J.-L.
(2023). CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges. Cancers, 15(3), 968.
https://doi.org/10.3390/cancers15030968